Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

DKFZ Deutsche Krebsforschungszentrum is a German private company that operates as a cancer research center.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Shenzhen Kangjuzheng Pharmaceutical Technology Co., Ltd., established on 2011-08-10, Business scope includes general business items:Pharmaceutical R&D and technology transfer,Technical Services,technical consulting;Technical development and sales of biotechnology products,Technical Services,technology transfer;Sales of biological consumables;Class I medical device,Sales of laboratory equipment;Operating import and export business;Research and development of chemical products,Technology Transfer and Sales.(None of the above is legal,Administrative regulations,The State Council decides to specify items that require pre-approval and prohibition),The licensing program is:

Neoantigen is a high-tech and innovative enterprise specializing in the research and development of individualized tumor vaccines. It is committed to developing various individualized immunotherapy products based on neoantigens. The founder of the company proposed the concept of neoantigen-based therapy in China in 2005 and is one of the leaders in the research and development of neoantigen-related products in the world.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. engages in the development and manufacture of biopharmaceutical focused on antibody drugs. It provides clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. Its products include yisaipu and jiannipai. The company was founded on January 25, 2002 and is headquartered in Shanghai, China.

Hangzhou Xingao Biotechnology Co., Ltd., established on 2017-05-08, Business scope includes biotechnology,Technology development in the field of medical science and technology,Technical Services,technology transfer,technical consulting;Sales of biological products and pharmaceuticals;Import and export business of goods and technology**(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Lithuanian University of Health Sciences (Lithuanian: Lietuvos sveikatos mokslų universitetas, LSMU) is a medical school in Kaunas, Lithuania. The present-day Lithuanian University of Health Sciences is a consolidation of two institutions of higher education, Kaunas University of Medicine and the Lithuanian Veterinary Academy. It uses the Hospital of Lithuanian University of Health Sciences Kaunas Clinics and the Kaunas Red Cross Hospital as a teaching hospitals.

ICCAS was founded in 1956. ICCAS is a multi-disciplinary research institute dedicated to the basic research in broad fields of chemical sciences, and to the key developments of the innovative high technologies aiming to the imperative national needs and important strategic targets, as well as to the collaborative high-technology applications and transfers. ICCAS is one of China’s leading chemistry research institutions with high international reputation.

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. Its products include cardiovascular drugs and medical devices; cephalosporin antibiotics and raw materials; and bone resorption inhibitor drugs. The company was founded on November 3, 1998 and is headquartered in Shenzhen, China.

Shanghai Aiqi Pharmaceutical Technology Co., Ltd., established on 2012-07-24, Business scope includes general items:medical products,Development of biological products,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Development of pharmaceutical intermediates,Sales(In addition to drugs),laboratory consumables,Instrumentation,electronic product,cosmetic,Sales of daily necessities,And provide technology transfer in related fields,technical consulting,Technical Services,Import and export,Technology Import and Export,food business(Only sell prepackaged food).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai Institutes for Biological Sciences CAS is a private company headquartered in Shanghai, China, that operates as researching agency.

Guangdong New Era Life Technology Co., Ltd., established on 2018-12-06, Business scope includes research and development,Production:biomedicine(Operate with a valid license),biomedical materials,Functional Materials,Structural materials,nanomaterials,energy materials,Amorphous alloy;Production:Health Food and Health Supplies,cosmetic(Operate with a valid license);Sales:Equipment,Software and Auxiliary Equipment,communication equipment;Sales:medical instruments,food(Operate with a valid license);Technology PromotionTechnical Services,Technology patent transfer,technical consulting,technology development;Intelligent Control System and Robot,system integration,Big Data Technology Development,Equipment research and development;Import and export of goods and technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Medical Diagnostic Laboratories a reference laboratory, provides molecular diagnostic based testing services to laboratories, hospitals, and physicians worldwide. The company specializes in automated DNA-based molecular analysis.It provides clinicians from various specialties with diagnostic information to assist in the detection, diagnosis, evaluation, and treatment of bacterial, viral, and fungal infections, as well as genetic based testing and cancer diagnostics.

Yunnan Institute of Materia Medica, part of Yunnan Baiyao Group Co., Ltd., is a company headquartered in Kunming, China. The firm manufactures and distributes pharmaceutical drugs. Yunnan Baiyao Group Co., Ltd. acquired Yunnan Institute of Materia Medica from Yunnan Baiyao Holdings Co., Ltd. on November 26, 2012 for $16.13 million.

Shanghai Bokang Biotechnology Co., Ltd., established on 2014-09-24, Business scope includes technology development in the field of biotechnology,technology transfer,technical consulting,Technical Services;Sales of medical devices,Class II,Equipment,Instrumentation,Rubber products,Glass product. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Guangdong Dexin Pharmaceutical Co., Ltd. is a Chinese private company located in Shantou that manufactures pharmaceutical products.

Oncotech, Inc. provides molecular oncology testing services. The firm's services improve the survival and quality of life of cancer patients through its molecular oncology testing services. Oncotech provides its testing services to hospitals in the US. The company was founded in 1985 and is headquartered in Tustin, CA.

Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (doing business as Chia Tai-Tianqing Pharmaceutical Co Ltd) is a company headquartered in Lianyungang, China. The firm manufactures pharmaceutical products. It was founded in 1969. Kang Xin Yu is the current CEO of the firm.

Hefei Qixing Pharmaceutical Technology Co., Ltd., established on 2003-03-18, Business scope includes pharmaceuticals,Healthy food,food research and development,Technology transfer and service.